Bicycle Therapeutics (BCYC) Other Non-Current Liabilities (2018 - 2026)

Bicycle Therapeutics posted quarterly Other Non-Current Liabilities of $973000.0 for Q1 2026, down 12.81% year-on-year from $1.1 million in Q1 2025, and down 5.72% on a QoQ basis from $1.0 million in Q4 2025.

Bicycle Therapeutics (BCYC) has 9 years of Other Non-Current Liabilities data on file, last reported at $973000.0 in Q1 2026.

  • For the quarter ending Q1 2026, Other Non-Current Liabilities fell 12.81% year-over-year to $973000.0; the trailing twelve-month figure through Mar 2026 stood at $973000.0 (down 12.81% YoY), and the FY2025 full-year result was $1.0 million, down 7.94% from the prior year.
  • Other Non-Current Liabilities for Q1 2026 stood at $973000.0, down from $1.0 million in the prior quarter.
  • Across five years, Other Non-Current Liabilities topped out at $6.0 million in Q3 2024 and bottomed at $973000.0 in Q1 2026.
  • The 5-year median for Other Non-Current Liabilities is $3.4 million (2022), against an average of $3.1 million.
  • The widest annual swing landed in 2024, when Other Non-Current Liabilities soared 38.16%; it then slumped 81.67% in 2025.
  • A 5-year view of Other Non-Current Liabilities shows it stood at $3.8 million in 2022, then advanced by 19.59% to $4.6 million in 2023, then slumped by 75.52% to $1.1 million in 2024, then decreased by 7.94% to $1.0 million in 2025, then declined by 5.72% to $973000.0 in 2026.
  • The last three Other Non-Current Liabilities figures came in at $973000.0 (Q1 2026), $1.0 million (Q4 2025), and $1.1 million (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Quantum Biopharma 1,216,509.61 Bn 1,216,509.61 Bn -
2 Alterity Therapeutics 764,224.41 Bn 764,224.38 Bn -
3 Legend Biotech 2,716.00 Bn 2,715.71 Bn 242.10 Mn
4 Nanobiotix 2,248.83 Bn 2,248.77 Bn -
5 Akari Therapeutics 1,951.18 Bn 1,951.17 Bn -
6 Vertex Pharmaceuticals 113.69 Bn 106.44 Bn 2.59 Bn
7 Evaxion A 64.16 Bn 64.14 Bn -
8 Regeneron Pharmaceuticals 63.94 Bn 55.18 Bn 3.31 Bn
9 Alnylam Pharmaceuticals 40.13 Bn 37.12 Bn 959.66 Mn
10 Bicycle Therapeutics 326.82 Mn 326.82 Mn -

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 973,000.00
Dec 31, 2025 1.03 Mn
Sep 30, 2025 1.09 Mn
Jun 30, 2025 1.14 Mn
Mar 31, 2025 1.12 Mn
Dec 31, 2024 1.12 Mn
Sep 30, 2024 5.96 Mn
Jun 30, 2024 4.70 Mn
Mar 31, 2024 4.61 Mn
Dec 31, 2023 4.58 Mn
Sep 30, 2023 4.32 Mn
Jun 30, 2023 4.33 Mn
Mar 31, 2023 4.08 Mn
Dec 31, 2022 3.83 Mn
Sep 30, 2022 3.16 Mn
Jun 30, 2022 3.26 Mn
Mar 31, 2022 3.36 Mn
Dec 31, 2021 3.28 Mn
Sep 30, 2021 3.04 Mn
Jun 30, 2021 2.96 Mn
Mar 31, 2021 2.81 Mn
Dec 31, 2020 2.61 Mn
Sep 30, 2020 2.31 Mn
Jun 30, 2020 2.09 Mn
Mar 31, 2020 2.01 Mn
Dec 31, 2019 2.00 Mn
Sep 30, 2019 1.43 Mn
Jun 30, 2019 1.26 Mn
Dec 31, 2018 897,000.00